Ciaffoni Joseph's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Feb 14, 2023
- Accession no.
- 0001062993-23-003475
- Filed
- Feb 14, 2023
- Trade date
- Feb 10-13, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $302.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaffoni JosephCIK 0001443841 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 | Common Stock | AGrant or awardAcquired | +117,500 | $0.00 | $0 | 366,250 | Direct | |
| Feb 10, 2023 | Common Stock | AGrant or awardAcquired | +137,694 | – | – | 503,944 | Direct | |
| Feb 10, 2023 | Common Stock | FTax withholdingDisposed | −44,121 | $26.75 | −$1,180,236.75 | 459,823 | Direct | |
| Feb 10, 2023 | Common Stock | FTax withholdingDisposed | −59,736 | $26.75 | −$1,597,938 | 400,087 | Direct | |
| Feb 13, 2023 | Common Stock | MOption exerciseAcquired | +11,250 | $15.90 | +$178,875 | 411,337 | Direct | |
| Feb 13, 2023 | Common Stock | SSaleDisposed | −11,250 | $26.88 | −$302,400 | 400,087 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | Common Stock | MOption exerciseDisposed | −11,250 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.